The focus of the study was to implement a new workflow for circulating tumor cells (CTCs) characterization that would allow the analysis of CTCs on a cytomorphological and molecular level in patients with diagnosed gynecological cancer. Our findings may be useful in future cancer patient management. The study introduces a size-based enrichment (MetaCell(®)) method for the separation of viable CTCs, followed by CTCs culturing in vitro and gene expression characterization. It is based on the observation of CTCs and DTCs (Disseminated Tumor Cells) in several case studies of ovarian, endometrial and cervical cancer by means of cytomorphology and gene expression profiling. The viability of the enriched CTCs was estimated using vital and lethal fluorescence nuclear staining. This type of staining may be predictive for the success rate of subsequent CTC growth in vitro. To identify CTCs in the enriched CTC fraction, cytomorphological evaluations based on vital fluorescence staining were followed by gene expression analysis of tumor-associated (TA) genes. Cytokeratin expression (KRT7, KRT19) was analyzed in combination with MUC1, MUC16, CD24, CD44 and ALDH1. Gene expression analysis has shown that short-term in vitro culture enhanced the differentiation process of the captured CTCs growing on a membrane. On the other hand, redundant white blood cells captured on the membrane were eliminated during a short-term culture. The most frequently elevated genes in ovarian cancer (serous type) are EPCAM, KRT19 and MUC1. It has been demonstrated that CTC presence revealed by cytomorphological evaluation may be usefully complemented by TA-gene expression analysis, to increase the sensitivity of the analysis.

Department of Biochemistry Institute of Laboratory Diagnostics University Hospital Kralovske Vinohrady Srobarova 50 Prague Czech Republic

Department of Laboratory Genetics Institute of Laboratory Diagnostics University Hospital Kralovske Vinohrady Srobarova 50 Prague Czech Republic

Department of Laboratory Genetics Institute of Laboratory Diagnostics University Hospital Kralovske Vinohrady Srobarova 50 Prague Czech Republic ; 3rd Department of Surgery 1st Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic ; Department of Histology and Embryology Wroclaw Medical University Chalubinskiego 6a 50 368 Wroclaw Poland

Division of Surgical Oncology and Department of Oncology Wroclaw Medical University Plac Hirszfelda 12 53 413 Wrocław Poland ; Lower Silesian Oncology Centre pl Hirszfelda 12 53 413 Wroclaw Poland

Zobrazit více v PubMed

Eliasova P, Kolostova K, Kobierzycki C, Bobek V. Clinical studies monitoring circulating and disseminated tumor cells in gastrointestinal cancers. Folia Histochem Cytobiol. 2013;51:265–77. PubMed

Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev. 2009;35:463–74. PubMed

Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol. 2013;88:338–56. PubMed

Mego M, Reuben JM. Prognostic and Predictive Role of Circulating Tumor Cells in Breast Cancer. Curr Breast Cancer Rep. 2014;6:251–259.

Friedlander TW, Premasekharan G, Paris PL. Looking back, to the future of circulating tumor cells. Pharmacol and Ther. 2014;142:271–280. PubMed

Song Y, Ji L, Yang L. Advances in techniques for detecting circulating tumor cells. Chinese J Clin Oncol. 2012;39:1859–1863.

Kolostova K, Zhang Y, Hoffman RM, Bobek V. In vitro culture and characterization of human lung cancer circulating tumor cells isolated by size exclusion from an orthotopic nude-mouse model expressing fluorescent protein. J Fluoresc. 2014;24:1531–6. PubMed PMC

Bobek V, Matkowski R, Gürlich R, Grabowski K, Szelachowska J, Lischke R, Schützner J, Harustiak T, Pazdro A, Rzechonek A, Kolostova K. Cultivation of circulating tumor cells in esophageal cancer. Folia Histochem Cytobiol. 2014;52:171–7. PubMed

Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial-mesenchymal transition: A hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology. 2012;79:195–208. PubMed

Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7:1–11. PubMed PMC

Wang J, El-Bahrawy MA. Expression profile of mucins in ovarian mucinous tumors: Distinguishing primary ovarian from metastatic tumors. Int J Gynecol Pathol. 2014;33:166–175. PubMed

Hong B, Zu Y. Detecting circulating tumor cells: Current challenges and new trends. Theranostics. 2013;3:377–394. PubMed PMC

Coumans FAW, Siesling S, Terstappen LWMM. Detection of cancer before distant metastasis. BMC Cancer. 2013;13:283. PubMed PMC

Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods. 2010;50:289–297. PubMed

Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–572. PubMed

Esmaeilsabzali H, Beischlag TV, Cox ME, Parameswaran AM, Park EJ. Detection and isolation of circulating tumor cells: principles and methods. Biotechnol Adv. 2013;31:1063–84. PubMed

Qi XW, Jiang J. Advances in detection methods of circulating breast-tumor cells. Chinese Journal of Cancer Prevention and Treatment. 2010;17:1586–1590.

van de Stolpe A, Pantel K, Sleijfer S, Terstappen LW, den Toonder JM. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res. 2011;71:5955–60. PubMed

Cegan M, Kolostova K, Matkowski R, Broul M, Schraml J, Fiutowski M, Bobek V. In vitro culturing of viable circulating tumor cells of urinary bladder cancer. Int J Clin Exp Pathol. 2014;7:7164–7171. PubMed PMC

Mavroudis D. Circulating cancer cells. Ann Oncol. 2010;21:95–100. PubMed

Lowes LE, Allan AL. Recent advances in the molecular characterization of circulating tumor cells. Cancers. 2014;6:595–624. PubMed PMC

Ušiaková Z, Mikulova V, Pintérová D, Brychta M, Valchar J, Kubecova M, Tesarova P, Bobek V, Kološtová K. Circulating tumor cells in patients with breast cancer: Monitoring chemotherapy success. In Vivo. 2014;28:605–614. PubMed

Circulating tumor cells in patients with cervical cancer undergoing chemoradiotherapy combined with brachytherapy

Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer

Circulating Tumor Cells: Fluid Surrogates of Solid Tumors

Molecular characterization of circulating tumor cells in ovarian cancer